ASCO Myeloma Update: More Promising Medicines on the Way
Dr. James Berenson gives his perspective on the latest drug development updates from ASCO 2012
Experts & Guests
James Berenson, M.D.
Founder, President and Medical and Scientific Director, Institute for Myeloma and Bone Cancer ResearchJames Berenson, M.D. is the Founder, President & Chief Executive Officer of the Institute for Myeloma and Bone Cancer Research. Dr. Berenson has specialized in research related to myeloma and metastatic bone disease both in the basic and clinical areas for more than 25 years. He has been involved in many of the major breakthroughs that have brought new treatments for... more >